| 1 |
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J. and Serguera, C. (2006) Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 17684-17689.
DOI
ScienceOn
|
| 2 |
Yanez-Munoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., Duran, Y., Bartholomae, C., von Kalle, C., Heckenlively, J. R., Kinnon, C., Ali, R. R. and Thrasher, A. J. (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12, 348-353.
DOI
ScienceOn
|
| 3 |
Cattoglio, C., Pellin, D., Rizzi, E., Maruggi, G., Corti, G., Miselli, F., Sartori, D., Guffanti, A., Di Serio, C., Ambrosi, A., De Bellis, G. and Mavilio, F. (2010) High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 116, 5507-5517.
DOI
ScienceOn
|
| 4 |
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A., Chanda, S. K., Konig, R., Malani, N., Berry, C. C. and Bushman, F. D. (2011) HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 7, e1001313.
DOI
ScienceOn
|
| 5 |
Konig, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T., Chiang, C. Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., Seidel, S., Opaluch, A. M., Caldwell, J. S., Weitzman, M. D., Kuhen, K. L., Bandyopadhyay, S., Ideker, T., Orth, A. P., Miraglia, L. J., Bushman, F. D., Young, J. A. and Chanda, S. K. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60.
DOI
ScienceOn
|
| 6 |
Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C. and Bushman, F. D. (2007) HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17, 1186-1194.
DOI
ScienceOn
|
| 7 |
Tan, W., Dong, Z., Wilkinson, T. A., Barbas, C. F.,3rd and Chow, S. A. (2006) Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J. Virol. 80, 1939-1948.
DOI
ScienceOn
|
| 8 |
Katz, R. A., Merkel, G. and Skalka, A. M. (1996) Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles. Virology. 217, 178-190.
DOI
ScienceOn
|
| 9 |
Goulaouic, H. and Chow, S. A. (1996) Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein. J. Virol. 70, 37-46.
|
| 10 |
Bushman, F. D. (1994) Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. U.S.A. 91, 9233-9237.
DOI
ScienceOn
|
| 11 |
Meekings, K. N., Leipzig, J., Bushman, F. D., Taylor, G. P. and Bangham, C. R. (2008) HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 4, e1000027.
DOI
ScienceOn
|
| 12 |
Gillet, N. A., Malani, N., Melamed, A., Gormley, N., Carter, R., Bentley, D., Berry, C., Bushman, F. D., Taylor, G. P. and Bangham, C. R. (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117, 3113-3122.
DOI
ScienceOn
|
| 13 |
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., Berry, C. C., Ecker, J. R. and Bushman, F. D. (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2, e60.
DOI
ScienceOn
|
| 14 |
Appa, R. S., Shin, C. G., Lee, P. and Chow, S. A. (2001) Role of the nonspecific DNA-binding region and alpha helices within the core domain of retroviral integrase in selecting target DNA sites for integration. J. Biol. Chem. 276, 45848-45855.
DOI
ScienceOn
|
| 15 |
Maertens, G. N., Hare, S. and Cherepanov, P. (2010) The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 468, 326-329.
DOI
ScienceOn
|
| 16 |
Studamire, B. and Goff, S. P. (2008) Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology. 5, 48.
DOI
ScienceOn
|
| 17 |
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R. and Bushman, F. (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11, 1287-1289.
DOI
ScienceOn
|
| 18 |
Schroder, A. R., Shinn, P., Chen, H., Berry, C., Ecker, J. R. and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
DOI
ScienceOn
|
| 19 |
Shun, M. C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P. and Engelman, A. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 21, 1767-1778.
DOI
ScienceOn
|
| 20 |
Kim, S., Kim, N., Dong, B., Boren, D., Lee, S. A., Das Gupta, J., Gaughan, C., Klein, E. A., Lee, C., Silverman, R. H. and Chow, S. A. (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J. Virol. 82, 9964-9977.
DOI
ScienceOn
|
| 21 |
Mitchell, R. S., Beitzel, B. F., Schroder, A. R., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R. and Bushman, F. D. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2, E234.
DOI
ScienceOn
|
| 22 |
Ciuffi, A., Mitchell, R. S., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R. and Bushman, F. D. (2006) Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol. Ther. 13, 366-373.
DOI
ScienceOn
|
| 23 |
Crise, B., Li, Y., Yuan, C., Morcock, D. R., Whitby, D., Munroe, D. J., Arthur, L. O. and Wu, X. (2005) Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79, 12199-12204.
DOI
ScienceOn
|
| 24 |
Monse, H., Laufs, S., Kuate, S., Zeller, W. J., Fruehauf, S. and Uberla, K. (2006) Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors. J. Virol. 80, 8145-8150.
DOI
ScienceOn
|
| 25 |
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi Sergi, L., Benedicenti, F., Ambrosi, A., Di Serio, C., Doglioni, C., von Kalle, C. and Naldini, L. (2006) Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24, 687-696.
DOI
ScienceOn
|
| 26 |
Hematti, P., Hong, B. K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I. E., Eckfeldt, C. E., Sharma, Y., Schmidt, M., von Kalle, C., Persons, D. A., Billings, E. M., Verfaillie, C. M., Nienhuis, A. W., Wolfsberg, T. G., Dunbar, C. E. and Calmels, B. (2004) Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2, e423.
DOI
ScienceOn
|
| 27 |
Nowrouzi, A., Dittrich, M., Klanke, C., Heinkelein, M., Rammling, M., Dandekar, T., von Kalle, C. and Rethwilm, A. (2006) Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87, 1339-1347.
DOI
|
| 28 |
Lim, K. I., Klimczak, R., Yu, J. H. and Schaffer, D. V. (2010) Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties. Proc. Natl. Acad. Sci. U.S.A. 107, 12475-12480.
DOI
ScienceOn
|
| 29 |
Tsukahara, T., Agawa, H., Matsumoto, S., Matsuda, M., Ueno, S., Yamashita, Y., Yamada, K., Tanaka, N., Kojima, K. and Takeshita, T. (2006) Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line. Biochem. Biophys. Res. Commun. 345, 1099-1107.
DOI
ScienceOn
|
| 30 |
Maruggi, G., Porcellini, S., Facchini, G., Perna, S. K., Cattoglio, C., Sartori, D., Ambrosi, A., Schambach, A., Baum, C., Bonini, C., Bovolenta, C., Mavilio, F. and Recchia, A. (2009) Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Mol. Ther. 17, 851-856.
DOI
ScienceOn
|
| 31 |
Beard, B. C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D. G., Jacobs, M. A., Kaul, R., Kiem, H. P. and Trobridge, G. D. (2007) Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol. Ther. 15, 1356-1365.
DOI
ScienceOn
|
| 32 |
Felice, B., Cattoglio, C., Cittaro, D., Testa, A., Miccio, A., Ferrari, G., Luzi, L., Recchia, A. and Mavilio, F. (2009) Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. PLoS One. 4, e4571.
DOI
ScienceOn
|
| 33 |
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Servida, P., Miniero, R., Roncarolo, M. G. and Bordignon, C. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
DOI
ScienceOn
|
| 34 |
Moalic, Y., Felix, H., Takeuchi, Y., Jestin, A. and Blanchard, Y. (2009) Genome areas with high gene density and CpG island neighborhood strongly attract porcine endogenous retrovirus for integration and favor the formation of hot spots. J. Virol. 83, 1920-1929.
DOI
ScienceOn
|
| 35 |
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F., Fischer, A. and Cavazzana-Calvo, M. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
DOI
ScienceOn
|
| 36 |
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., Cavallesco, R., Gillet-Legrand, B., Caccavelli, L., Sgarra, R., Maouche-Chretien, L., Bernaudin, F., Girot, R., Dorazio, R., Mulder, G. J., Polack, A., Bank, A., Soulier, J., Larghero, J., Kabbara, N., Dalle, B., Gourmel, B., Socie, G., Chretien, S., Cartier, N., Aubourg, P., Fischer, A., Cornetta, K., Galacteros, F., Beuzard, Y., Gluckman, E., Bushman, F., Hacein-Bey-Abina, S. and Leboulch, P. (2010) Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 467, 318-322.
DOI
ScienceOn
|
| 37 |
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H., Naundorf, S., Brinkmann, A., Deichmann, A., Fischer, M., Ball, C., Pilz, I., Dunbar, C., Du, Y., Jenkins, N. A., Copeland, N. G., Luthi, U., Hassan, M., Thrasher, A. J., Hoelzer, D., von Kalle, C., Seger, R. and Grez, M. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
DOI
ScienceOn
|
| 38 |
Coffin, J. M., Hughes, S. H. and Varmus, H. E. (1997) Retroviruses, Cold Spring Harbor Lab. Press, New York, U.S.A.
|
| 39 |
Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
DOI
ScienceOn
|
| 40 |
Wu, X., Li, Y., Crise, B. and Burgess, S. M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
DOI
ScienceOn
|
| 41 |
Knipe, D. M. and Howley, P. M. (2006) Fields Virology, 5th ed., Lippincott Williams & Wilkins, Philadelphia, USA.
|
| 42 |
Doi, K., Wu, X., Taniguchi, Y., Yasunaga, J., Satou, Y., Okayama, A., Nosaka, K. and Matsuoka, M. (2005) Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. Blood 106, 1048-1053.
DOI
ScienceOn
|
| 43 |
Guss, D. A. (1994) The acquired immune deficiency syndrome: an overview for the emergency physician, Part 2. J. Emerg. Med. 12, 491-497.
DOI
ScienceOn
|
| 44 |
Guss, D. A. (1994) The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1. J. Emerg. Med. 12, 375-384.
DOI
ScienceOn
|
| 45 |
Fan, H. (2007) A new human retrovirus associated with prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 1449-1450.
DOI
ScienceOn
|
| 46 |
Shimotohno, K. and Temin, H. M. (1982) Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature 299, 265-268.
DOI
ScienceOn
|
| 47 |
Schambach, A. and Baum, C. (2008) Clinical application of lentiviral vectors - concepts and practice. Curr. Gene Ther. 8, 474-482.
DOI
ScienceOn
|
| 48 |
Watanabe, S. and Temin, H. M. (1983) Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 3, 2241-2249.
DOI
|
| 49 |
Schaffer, D. V., Koerber, J. T. and Lim, K. I. (2008) Molecular engineering of viral gene delivery vehicles. Annu. Rev. Biomed. Eng. 10, 169-194.
DOI
ScienceOn
|
webmaster
